Skip to content

Subthalamic Nucleus Stimulation Effect on Gait Symmetry and Freezing of Gait

Subthalamic Nucleus Stimulation Effect on Gait Symmetry and Freezing of Gait

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02704195
Acronym
STIMSYM
Enrollment
12
Registered
2016-03-09
Start date
2014-04-30
Completion date
2016-04-30
Last updated
2016-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Parkinson disease, Deep brain stimulation, Freezing of Gait

Brief summary

Impact of unilateral modulation of deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson's disease

Detailed description

Unilateral modulation of subthalamic stimulation and its impact on freezing of gait in Parkinson's disease will be studied. In a cross-over, doubleblind, randomized study, a 30% reduction of stimulation intensity of the less impacted side will be compared with chronic treatment with regard to frequency and duration of freezing of gait episodes.

Interventions

PROCEDUREUnilateral reduction of stimulation

30% unilateral reduction of Subthalamic nucleus stimulation

PROCEDUREChronic Subthalamic nucleus stimulation

This arm is the reference, with the best stimulation parameters

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

Patients affiliated to social security Patient with idiopathic parkinson's disease, with deep brain stimulation since at least one year Freezing of gait Able to give inform consent

Exclusion criteria

Patient under guardianship, legal guardianship Psychosis Severe depression Severe cognitive troubles (Mattis \< 130) Other neurologic or medical pathology interfering with gait

Design outcomes

Primary

MeasureTime frameDescription
improvement of Freezing of gait1 month after new stimulation parametersthe improvement will be measure with a composite score of items 12 + 13 on UPDRS II and items 10+11 on UPDRS III,

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026